Company chairman and CEO Alex Lukianov attributed the company's success to transactions that enhanced its penetration into the lateral lumbar interbody fusion market and NeuroVision market. The additional acquisition of Impulse Monitoring increased the company's platform during the third quarter as well.
Related Articles on Orthopedic Device Companies:
Integra LifeSciences Reports $202M 3Q Revenue, Driven by Orthopedics Products
Overseas Markets Drive Zimmer's 3Q Net Sales Increase
Orthofix Spine Sales Decrease Offset by Orthopedic Sales Increase
NuVasive Reports $132.9M 3Q Revenue, 10.5% IncreaseWritten by Laura Miller | November 01, 2011
NuVasive, a spine device company, recently announced revenue of $132.9 million during the third quarter of 2011, a 10.5 percent increase over the same period last year, according to a NuVasive news release.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.